Blue Horizon Skin Care

Call +1 (855) 645-2583International: +1 (866) 663-3102

Sickle-Cell Disease

Sickle-Cell Disease (SCD)

Sickle-cell disease (SCD), sickle-cell anemia (SCA) or drepanocytosis, is an autosomalrecessive genetic blood disorder with overdominance, characterized by red blood cells that assume an abnormal, rigid, sickle shape.  Sickling decreases the cells’ flexibility and results in a risk of various complications. The sickling occurs because of a mutation in the hemoglobin gene. Life expectancy is shortened. In 1994, in the US, the average life expectancy of persons with this condition was estimated to be 42 years in males and 48 years in females,  but today, thanks to better management of the disease, patients can live into their 50s or beyond.

Sickle-cell anaemia is the name of a specific form of sickle-cell disease in which there is homozygosity for the mutation that causes HbS. Sickle-cell anaemia is also referred to as “HbSS”, “SS disease”, “haemoglobin S” or permutations thereof. In heterozygous people, who have only one sickle gene and one normal adult haemoglobin gene, it is referred to as “HbAS” or “sickle cell trait”. Other, rarer forms of sickle-cell disease include sickle-haemoglobin C disease (HbSC), sickle beta-plus-thalassaemia (HbS/β+) and sickle beta-zero-thalassaemia (HbS/β0). These other forms of sickle-cell disease are compound heterozygous states in which the person has only one copy of the mutation that causes HbS and one copy of another abnormal haemoglobin allele.

To find out more about how you may benefit from our stem cell research protocol, please complete our Contact Us form and one of our physicians will reach out to you for a private consultation.